1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Community Health Worker (Entry-Level) Course - Remote is sponsored by Oregon State University Professional and Continuing Education, Oregon State University College of Health, and Eastern Oregon Coordinated Care Organization (EOCCO). This online Community Health Worker (CHW) training program is designed to support progress in public health outcomes and provide meaningful career pathways for healthcare staff serving in the region.
The course aims to prepare students for work as entry-level CHWs and equip healthcare staff in other roles with a community health perspective, addressing all competencies required for approval as a CHW training program in Oregon.
Get alerted about grants like this
Save a search for “Oregon State University Professional and Continuing Education, Oregon State University College of Health, and Eastern Oregon Coordinated Care Organization (EOCCO)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Individuals interested in becoming Community Health Workers or healthcare staff serving in other roles. Confirm the full requirements in the official notice before applying.
The published deadline was June 7, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Community Health Worker (Entry-Level) Course - Remote is funded by Oregon State University Professional and Continuing Education, Oregon State University College of Health, and Eastern Oregon Coordinated Care Organization (EOCCO). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
The $175 million Talent Search competition marks the first time the Labor Department has administered Education grants. A deep analysis of what changed, who benefits, and how college access organizations should respond.
Read articleNIH's 271% year-over-year jump in early-cycle multiyear awards — 601 grants worth $402M obligated by mid-May 2026 vs. 162 grants and $79M at the same point in 2025 — is shrinking the pool available for new R01s, R21s, and K-awards. The FY2027 budget request asks Congress to make the practice the default. Researchers need to model the squeeze, not assume it away.
Read articleDARPA and NSF launched a joint program on June 1 to fund university work on AI interpretability, control, and adversarial robustness. Awards run $750K to $3M+ per project, the forum launches this summer, and the universities listed in the AI Forge repository will sit closest to the money. The Request for Information closes June 22.
Read article